Focus and Scope

Pharmacy Action Journal (PAJ)is a scientific journal published by the Faculty of Pharmacy, Universitas 17 Augustus 1945 Jakarta. Pharmacy Action Journal (PAJ)is an Open Journal System for the results of community service and empowerment activities in the form of applying the field of pharmacy science. This journal is a periodical publication twice a year in april and October containing articles from the results of the dissemination of research-based community service activities in the pharmaceutical sector.

Pharmacy Action Journal (PAJ)accepts a collection of scientific articles with areas of study to the public regarding:

1. Community Partnership Program
2. Regional Partnership Program
3. Partnership Program with Corporate CSR or Local Government
4. Community Entrepreneurship Development Program
5. MSME Product Development Program
6. Regional Leading Product Development Program
7. Campus Intellectual Product Business Development Program
8. Partner Village Development Program
9. Real Work Study Program
10. Campus Technology Application Program

As well as other service programs related to the implementation of Community Service results in Indonesia. With articles that have primary citations and have never been published online or in print before.

Section Policies

Articles

Open Submissions

Indexed

Peer Reviewed

Publication Frequency

This journal is a periodical published twice a year in April and October

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Archiving

OJS LOCKSS system to create a distributed filing system among partitioned libraries and allow those libraries to create permanent archives if the purpose is for preservation and restoration.

Publication Ethic

To maintain the quality of manuscript and avoid publishing violation / plagiarism in the process of publishing, the editorial board establishes scientific publication ethics. The publication ethics rules apply to writers/authors, editors, reviewers, and journal/editorial managers. The publication ethics refers to The Committee on Publication Ethics (COPE).

Author Ethics

1. Reporting; Authors must provide information about the process and result of their research to the editor honestly, clearly, and thoroughly, and file their research data properly and safely. The manuscript must contain sufficient details and references that enable others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. The manuscript must follow journal submission guidelines.

2. Originality and plagiarism; Authors must ensure that the sent/submitted manuscript is original, written by themselves, derived from their own ideas and thoughts, and not plagiarizing other’s papers or ideas or thoughts. Authors are strictly prohibited from changing the cited reference names to other’s names.

3. Multiple or Concurrent Publication; Authors should not submit the same manuscript to more than one journal at the same time. It is unethical and unacceptable behavior. Multiple publications that originate from a research project must be clearly identified and refer to the main publication.

4. Acknowledgement of Source; Authors must acknowledge and cite all used and influential data sources in the book.

5. Multiple Submission; Authors must inform the editor that the manuscript has never been submitted to another journal publisher/publication. If there is a redundancy in submitting the manuscript to another publisher, the editor will reject the submitted manuscript.

6. Author Status; Authors must inform the editor that they have competence or qualification in a certain field or expertise in accordance with publishing science, namely librarianship. The Author who submitted the manuscript to the editor is the first author (co-author) so if a problem occurs in the process of publishing, it can be resolved immediately.  

7. Authorship of the Paper; Authors must describe individual contributions to their paper. The paper should be limited to those who have made a significant contribution to the conception, the design, the implementation or the interpretation of the reported study. Others who have contributed must be listed as co-author. In case the main contributors are listed as authors, those who have less contribution to research or publication are listed in the acknowledgment. Authors also ensure that they have seen and approved the submitted version of the manuscript and include their names as co-authors.

8. Fundamental Errors in the Paper; Authors must immediately inform the editor if errors are found in the paper, not only the results of the review but also of the edit. The errors include writing names, affiliations/agencies, quotes, and other writings that can reduce the meaning and substance of the paper. If that happens, the author must immediately propose improvements to the paper.

9. Disclosure and Conflicts of Interest; Authors must understand the scientific publications ethics above to avoid conflicts of interest with other parties, so that the paper can be processed smoothly and safely.

Editor Ethics

1. Publication Decisions; Based on the review report from the editorial board, editors may accept, reject, or request for modifications to the manuscript. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making such a decision. The editors must be responsible for every material they publish and must have procedures and policies to ensure the quality of them and maintain the integrity of the published notes.

2. Review of Manuscripts; Editors must ensure that they initially evaluate each manuscript for originality. The editors should organize and use peer review fairly and wisely. The editors should explain their peer review processes in the information for authors and indicate in which parts of journals are peer reviewed. The editors should use appropriate peer reviewers for papers that are considered for publication by selecting people with sufficient expertise and avoiding those with conflicts of interest.

3. Fair Play; Editors must ensure that they evaluate each received manuscript for author’s intellectual content without regard to gender, sex, race, religious belief, citizenship, etc. An important part of the responsibility to make fair and unbiased decisions is the enforcement of editorial independence and integrity principles. The editors are in a strong position by making decisions about publication, which is crucial that this process is as fair as possible.

4. Confidentiality; Editors must ensure that information regarding the author's submitted manuscript must be guarded. The editors critically assess any potential violation of data protection and patient confidentiality.

 5. Disclosure and Conflicts of Interest; Editors do not use unpublished materials for their own research without the express written consent of the author. The editors do not involve in manuscript decisions that they have conflicts of interest. 

Reviewer Ethics

1. Objectivity and Neutrality; Reviewers must be honest, objective, unbiased, independent, and only take a side with scientific truth. The process of manuscript reviewing is expressed professionally without discriminating gender, sex, business side, ethnicity, religious belief, race, intergroup, and citizenship of the author. The reviewers must state their views clearly with supporting arguments.   

2. Confidentiality; Each manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorised by the editor.

3. Promptness; Any selected reviewers who feel unqualified/uninterested in reviewing the manuscript or do not have sufficient time to review should immediately notify the editor and withdraw from the planning process.

4. Accuracy; Reviewers must respond within a reasonable time frame. The reviewers only agree to review the manuscript if they are reasonably certain that they can return the review within the proposed or mutually agreed time frame, and inform the journal immediately if they require an extension. In case the reviewers find it impossible to complete a manuscript review within the exact time, the information must be communicated to the editor so that it can be sent to another reviewer.

5. Acknowledgement of Sources; Reviewers should ensure that the reference/ text citation is appropriate and credible (accountable). If errors or irregularities are found in the writing of reference/text citation, they must immediately inform the editor so the author can improve according to the notes from the reviewers. The reviewers must also state to the editor if there are substantial similarities or overlaps between the under consideration manuscript and any other published articles.

6. Peer- review effectiveness; Reviewers must respond to editor’s submitted manuscript and work according to the specified peer-review time (maximum 2 weeks). In case that a reviewer finds it impossible to complete a manuscript review within the allotted time, they must inform the editor so that the manuscript can be sent to another reviewer.

7. Disclosure and Conflict of Interest; Privileged information or ideas obtained through review process must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Publication Charge

Article Processing Charge to be paid by the author is as follows:

Article Submission: IDR 0.00
Article Publication: IDR 350,000

Authorship Criteria

Pharmacy Action Journal adopts the guidelines of the International Committee of Medical Journal Editors (ICMJE), adapted to the context of Community Service (Pengabdian kepada Masyarakat/PkM) programs. All individuals listed as authors must meet the following four criteria:

1. Substantive Contribution to the Implementation of Community Service:

Made a significant contribution to the conceptual design, planning, or execution of the community service program/activity, or to the collection and analysis of data/evaluation of the activity's impact in the field.

2. Drafting and Revising the Manuscript:

Played an active role in drafting the manuscript or conducting a critical revision of the scientific substance and the methodology of the community service.

3. Final Approval:

Reviewed and approved the final version of the manuscript to be published.

4. Accountability and Responsibility:

Accepted responsibility for all aspects of the work presented in the article and ensured that any questions regarding the accuracy or integrity of any part of the activity or manuscript can be investigated and resolved thoroughly.

Plagiarism Policy

Pharmacy Action Journal is committed to upholding high standards of academic integrity and preventing any form of plagiarism and publication misconduct. All manuscripts submitted to this journal must be original work and must not have been previously published in any print or electronic media.

1. Plagiarism Screening

• All submitted manuscripts undergo plagiarism screening using anti-plagiarism software (such as Turnitin or iThenticate) prior to the peer-review process.

• Maximum Similarity Threshold: Manuscripts will only be proceeded to peer review if the overall text similarity index is below 20%, with similarity from a single source not exceeding 3%.

2. Prohibited Academic Misconduct

This policy addresses and penalizes the following violations:

1. Direct Plagiarism: Copying word-for-word text, sentences, or paragraphs from another source without clear attribution or quotation marks.

2. Self-Plagiarism / Auto-Plagiarism: Reusing substantial portions of one's own previously published work without proper citation.

3. Duplicate / Simultaneous Submission: Submitting the same manuscript to more than one journal concurrently.

4. Data Fabrication & Falsification: Inventing false data or manipulating field evaluation results of community engagement programs.

3. Actions & Sanctions

If plagiarism or academic misconduct is identified at any stage:

• Pre-publication:

  • If the similarity index is between 21% – 30%, the manuscript will be returned to the authors for rewriting, paraphrasing, and proper citation.

  • If the similarity index exceeds 30% or evidence of substantial plagiarism is found, the manuscript will be rejected immediately without review.

• Post-publication:

  • If plagiarism is proven after publication, the Editorial Board reserves the right to issue a Retraction in accordance with COPE (Committee on Publication Ethics) guidelines.

  • A formal Retraction Notice will be published and linked to the original article, and written notifications will be sent to the authors' affiliated institutions.

Conflict of Interest

Pharmacy Action Journal requires all authors, reviewers, and editors to declare any actual, potential, or perceived conflicts of interest that could inappropriately influence or bias their work, evaluations, or editorial decisions.

A conflict of interest exists when professional judgment concerning a primary interest (such as the validity of research or community service outcomes) may be influenced by a secondary interest (such as financial gain, personal relationships, or academic competition).

1. Author Responsibilities

• Declaration Statement: All authors must explicitly disclose any financial, personal, or professional relationships that might bias their work upon manuscript submission.

• Funding & Sponsorship: Authors must disclose all sources of financial support for the community engagement project, including grants, corporate sponsorships, equipment donations, or honoraria.

• Role of the Sponsor: Authors must state whether the funding organization had any role in the design of the program, data collection/evaluation, writing of the manuscript, or the decision to submit it for publication.

• No Conflicts Statement: If no competing interests exist, authors must include the following statement in the manuscript:

  "The authors declare that there are no conflicts of interest regarding the publication of this article."

2. Reviewer Responsibilities

• Reviewers must declare any conflicts of interest before agreeing to review a manuscript.

• Reviewers must decline the invitation to review if:

  • They have a recent or ongoing collaboration with any of the authors.

  • They belong to the same department, institution, or organization as the authors.

  • They have financial, personal, or competitive interests related to the work.

  • They feel unable to provide an objective and unbiased evaluation.

3. Editor and Editorial Board Responsibilities

• Editors who have a conflict of interest with a submitted manuscript (e.g., being an author/co-author, hailing from the same department, or having financial ties with sponsors) must recuse themselves from editorial decisions regarding that manuscript.

• An alternative member of the Editorial Board without competing interests will handle the peer-review process and editorial decision.

• Editors must not use unpublished information disclosed in a submitted manuscript for their own research or personal advantage.

4. Handling Undisclosed Conflicts

If an undisclosed conflict of interest is discovered before or after publication:

• The Editorial Board will follow the guidelines and flowcharts provided by the Committee on Publication Ethics (COPE).

• Consequences may include requesting a formal correction, issuing an Expression of Concern, or publishing a formal Retraction of the article.

Index

This journal has been awarded SINTA 5 accreditation, based on an assessment and formal recognition by the Ministry of Higher Education, Science, and Technology of the Republic of Indonesia. This achievement reflects the journal’s commitment to maintaining the quality of its scientific publications, implementing a rigorous peer-review process, and supporting the dissemination of high-quality research that contributes to the advancement of knowledge.

Further information regarding the accreditation status and the journal’s profile can be accessed via the official SINTA website at the following link:

https://sinta.kemdiktisaintek.go.id/journals/profile/14736

License

All published articles are licensed under a Creative Commons Attribution (CC BY) license, which allows the work to be used, distributed, and reproduced in any medium without restriction, provided that the original source and work are cited and appropriate attribution is given to the author(s).

Post-Publication Discussion

Pharmacy Action Journal is committed to promoting scientific integrity, transparency, and constructive scholarly communication. The journal recognizes that scientific discussion and critical evaluation are essential components of the scholarly publishing process, even after an article has been formally published.

The journal welcomes post-publication discussions, including scholarly comments, critical analyses, methodological clarifications, and evidence-based responses concerning articles published in the journal.

1. Scope of Post-Publication Discussion

Post-publication discussions may address the following aspects:

• Scientific validity, accuracy, and interpretation of published findings.

• Research methodology, study design, and statistical analysis.

• Reproducibility and reliability of research results.

• Ethical considerations and research integrity.

• Additional scientific evidence relevant to published articles.

• Constructive academic criticism and clarification of published findings.

All discussions must be scientifically justified, objective, respectful, and relevant to the published article.

2. Submission of Comments

Readers, researchers, reviewers, and other members of the scientific community are encouraged to submit comments or questions regarding published articles.

Comments may be submitted to the editorial office through the journal's official contact email or through the OJS platform, where applicable.

Submissions should include the article title, author names, DOI or publication URL, a clear description of the issue being discussed, and relevant supporting evidence or references.

3. Editorial Assessment

All post-publication comments will be evaluated by the editorial team to determine their relevance, scientific merit, and compliance with publication ethics.

The editorial team reserves the right to request additional information, seek independent expert opinions, or invite the original authors to respond.

Comments containing personal attacks, discriminatory statements, unsupported allegations, or inappropriate language will not be considered for publication.

4. Author Response

Authors of published articles may be invited to provide a scientific response or clarification regarding issues raised through post-publication discussion.

The journal encourages authors to respond professionally, transparently, and with appropriate scientific evidence.

5. Corrections, Expressions of Concern, and Retractions

If post-publication discussions identify substantial errors, ethical concerns, or issues affecting the reliability of published findings, the editorial team will evaluate the matter in accordance with applicable publication ethics guidelines, including those of the Committee on Publication Ethics (COPE).

Depending on the nature and severity of the issue, editorial actions may include:

• Publication of a correction or clarification.

• Publication of an expression of concern.

• Retraction of the published article when warranted.

Any formal editorial action will be clearly identified and linked to the original publication to maintain transparency and the integrity of the scholarly record.

6. Transparency and Publication of Discussions

Post-publication comments and author responses may be published on the journal's website or as formal scholarly correspondence, subject to editorial evaluation.

Published discussions will be appropriately linked to the original article whenever technically feasible.

The editorial team is responsible for ensuring that post-publication discussions contribute constructively to scientific knowledge and do not compromise ethical standards.

7. Confidentiality and Ethical Considerations

The journal will handle sensitive information and allegations of research misconduct confidentially, as appropriate, during the investigation process.

Individuals participating in post-publication discussions are expected to disclose relevant conflicts of interest and adhere to professional standards of scholarly communication.

Pharmacy Action Journal is committed to maintaining an open, responsible, and ethical environment for post-publication scholarly discussion and continuous improvement of scientific publications.